GeneNews Ltd (OTCMKTS:GNWSF) shares rose 27.7% on Wednesday . The company traded as high as $0.05 and last traded at $0.05, approximately 2,200 shares traded hands during mid-day trading. A decline of 71% from the average daily volume of 7,560 shares. The stock had previously closed at $0.04.
The firm has a 50 day moving average of $0.03 and a two-hundred day moving average of $0.06.
GeneNews (OTCMKTS:GNWSF) last posted its earnings results on Thursday, November 14th. The company reported ($0.01) EPS for the quarter. The business had revenue of $0.02 million during the quarter.
About GeneNews (OTCMKTS:GNWSF)
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.
Recommended Story: Bid-Ask Spread
Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with MarketBeat.com's FREE daily email newsletter.